151 related articles for article (PubMed ID: 20570859)
1. Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells.
Hofmann A; Gerrits B; Schmidt A; Bock T; Bausch-Fluck D; Aebersold R; Wollscheid B
Blood; 2010 Sep; 116(13):e26-34. PubMed ID: 20570859
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.
Strassberger V; Gutbrodt KL; Krall N; Roesli C; Takizawa H; Manz MG; Fugmann T; Neri D
J Proteomics; 2014 Mar; 99():138-51. PubMed ID: 24487095
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias.
Barber N; Belov L; Christopherson RI
Leuk Res; 2008 Feb; 32(2):315-22. PubMed ID: 17561254
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
6. [Expression pattern of myeloid differentiation-related transcription factor mRNA in differentiation of NB4 and HL-60 cells induced by all-trans retinoic acid].
Wu Y; Li XF; Yang JH; Liao XY; Huang HF; Chen YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):874-8. PubMed ID: 21867605
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
[TBL] [Abstract][Full Text] [Related]
9. All-trans-retinoic acid induces CD52 expression in acute promyelocytic leukemia.
Li SW; Tang D; Ahrens KP; She JX; Braylan RC; Yang L
Blood; 2003 Mar; 101(5):1977-80. PubMed ID: 12393392
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database.
Manzotti G; Parenti S; Ferrari-Amorotti G; Soliera AR; Cattelani S; Montanari M; Cavalli D; Ertel A; Grande A; Calabretta B
Cell Cycle; 2015; 14(16):2578-89. PubMed ID: 26102293
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
Popova EY; Claxton DF; Lukasova E; Bird PI; Grigoryev SA
Exp Hematol; 2006 Apr; 34(4):453-62. PubMed ID: 16569592
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
13. ICAT as a potential enhancer of monocytic differentiation: implications from the comparative proteome analysis of the HL60 cell line stimulated by all-trans retinoic acid and NSC67657.
Wang W; Zhang X; Deng K; Huang S; Mao X; Fu Y; Yi Z; Yan Y; Qiu Z
Cell Biochem Funct; 2009 Aug; 27(6):329-37. PubMed ID: 19569129
[TBL] [Abstract][Full Text] [Related]
14. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation.
Ohnishi K; Tobita T; Sinjo K; Takeshita A; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):599-608. PubMed ID: 9922051
[TBL] [Abstract][Full Text] [Related]
15. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.
Boutzen H; Saland E; Larrue C; de Toni F; Gales L; Castelli FA; Cathebas M; Zaghdoudi S; Stuani L; Kaoma T; Riscal R; Yang G; Hirsch P; David M; De Mas-Mansat V; Delabesse E; Vallar L; Delhommeau F; Jouanin I; Ouerfelli O; Le Cam L; Linares LK; Junot C; Portais JC; Vergez F; Récher C; Sarry JE
J Exp Med; 2016 Apr; 213(4):483-97. PubMed ID: 26951332
[TBL] [Abstract][Full Text] [Related]
16. Effect of differentiating agents (all-trans retinoic acid and phorbol 12-myristate 13-acetate) on drug sensitivity of HL60 and NB4 cells in vitro.
Jasek E; Mirecka J; Litwin JA
Folia Histochem Cytobiol; 2008; 46(3):323-30. PubMed ID: 19056536
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
18. Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-
Smitheman KN; Severson TM; Rajapurkar SR; McCabe MT; Karpinich N; Foley J; Pappalardi MB; Hughes A; Halsey W; Thomas E; Traini C; Federowicz KE; Laraio J; Mobegi F; Ferron-Brady G; Prinjha RK; Carpenter CL; Kruger RG; Wessels L; Mohammad HP
Haematologica; 2019 Jun; 104(6):1156-1167. PubMed ID: 30514804
[TBL] [Abstract][Full Text] [Related]
19. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
[TBL] [Abstract][Full Text] [Related]
20. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
